English | Español

Vifor Pharma
Press release submission | Dec 10, 2021

First patient enrolled in phase-IIa study of vamifeport in patients with sickle cell disease
Nicholas Gueguen | Aug 13, 2017

Vifor Pharma begins new tests of Ferinject in patients with heart failure, iron deficiency

Robert Hadley | Apr 28, 2017

Vifor Pharma offers grants aimed at combating iron deficiency
Gene Johnson | Mar 1, 2017

Vifor buys rights to sell renal treatment in most of Asia
Carol Ostrow | Feb 16, 2017

Swiss company holds iron deficiency to the fire
Keri Carbaugh | Jan 6, 2017

Kidney Health Alliance expands to include CCX140
Amanda Rupp | Jun 11, 2016

Vifor Pharma grants Pfizer commercialization rights
Amanda Rupp | May 25, 2016

Vifor Pharma buys rights to rare renal disease treatment

Trending
+ Pharmaceuticals
Patient Daily | Jul 22, 2025

Deputy VP of Public Affairs of PhRMA: 'It's time for Congress to fix the 340B Drug Pricing Program'
Patient Daily | Jul 24, 2025

Long School of Medicine is largest physician trainer in South Texas
Patient Daily | Jul 25, 2025

Healthcare CEO on 340B reform: ‘It’s the abuse by very large, very profitable, tax-exempt institutions that I think needs to change'
Patient Daily | Jul 25, 2025

Balloon sinuplasty marks 20 years since FDA approval